These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25414781)

  • 21. Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis.
    Stevens M; Oltean S
    Cells; 2019 Mar; 8(4):. PubMed ID: 30925751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF-A splicing: the key to anti-angiogenic therapeutics?
    Harper SJ; Bates DO
    Nat Rev Cancer; 2008 Nov; 8(11):880-7. PubMed ID: 18923433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VEGF₁₂₁b and VEGF₁₆₅b are weakly angiogenic isoforms of VEGF-A.
    Catena R; Larzabal L; Larrayoz M; Molina E; Hermida J; Agorreta J; Montes R; Pio R; Montuenga LM; Calvo A
    Mol Cancer; 2010 Dec; 9():320. PubMed ID: 21194429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy.
    Varey AH; Rennel ES; Qiu Y; Bevan HS; Perrin RM; Raffy S; Dixon AR; Paraskeva C; Zaccheo O; Hassan AB; Harper SJ; Bates DO
    Br J Cancer; 2008 Apr; 98(8):1366-79. PubMed ID: 18349829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
    Zhao M; Shi X; Liang J; Miao Y; Xie W; Zhang Y; Li X
    Exp Eye Res; 2011 Dec; 93(6):921-6. PubMed ID: 22067127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and functional characterization of two alternative splicing variants of mouse Endothelial Cell-Specific Chemotaxis Regulator (ECSCR).
    Wu W; Shi C; Ma F; Balducci J; Huang H; Ji HL; Chang Y; Huang Y
    Int J Mol Sci; 2012; 13(4):4920-4936. PubMed ID: 22606020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
    Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
    Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.
    Vempati P; Popel AS; Mac Gabhann F
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):1-19. PubMed ID: 24332926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia.
    Hulse RP; Beazley-Long N; Hua J; Kennedy H; Prager J; Bevan H; Qiu Y; Fernandes ES; Gammons MV; Ballmer-Hofer K; Gittenberger de Groot AC; Churchill AJ; Harper SJ; Brain SD; Bates DO; Donaldson LF
    Neurobiol Dis; 2014 Nov; 71():245-59. PubMed ID: 25151644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The balance of proangiogenic and antiangiogenic VEGFA isoforms regulate follicle development.
    McFee RM; Rozell TG; Cupp AS
    Cell Tissue Res; 2012 Sep; 349(3):635-47. PubMed ID: 22322423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two Novel Heparin-binding Vascular Endothelial Growth Factor Splices, L-VEGF144 and L-VEGF138, are Expressed in Human Glioblastoma Cells.
    Shen CC; Cheng WY; Chiao MT; Liang YJ; Mao TF; Liu BS
    Curr Neurovasc Res; 2016; 13(3):207-18. PubMed ID: 27220431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.
    Peach CJ; Mignone VW; Arruda MA; Alcobia DC; Hill SJ; Kilpatrick LE; Woolard J
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolution of alternative splicing exons in vascular endothelial growth factor A.
    Xu J; Dou T; Liu C; Fu M; Huang Y; Gu S; Zhou Y; Xie Y
    Gene; 2011 Nov; 487(2):143-50. PubMed ID: 21782909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.
    Hamdollah Zadeh MA; Amin EM; Hoareau-Aveilla C; Domingo E; Symonds KE; Ye X; Heesom KJ; Salmon A; D'Silva O; Betteridge KB; Williams AC; Kerr DJ; Salmon AH; Oltean S; Midgley RS; Ladomery MR; Harper SJ; Varey AH; Bates DO
    Mol Oncol; 2015 Jan; 9(1):167-78. PubMed ID: 25224594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-angiogenic isoform of vascular endothelial growth factor-A in cardiovascular and renal disease.
    Kikuchi R; Stevens M; Harada K; Oltean S; Murohara T
    Adv Clin Chem; 2019; 88():1-33. PubMed ID: 30612603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice.
    Konopatskaya O; Churchill AJ; Harper SJ; Bates DO; Gardiner TA
    Mol Vis; 2006 May; 12():626-32. PubMed ID: 16735996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases.
    Oltean S; Gammons M; Hulse R; Hamdollah-Zadeh M; Mavrou A; Donaldson L; Salmon AH; Harper SJ; Ladomery MR; Bates DO
    Biochem Soc Trans; 2012 Aug; 40(4):831-5. PubMed ID: 22817743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shift in VEGFA isoform balance towards more angiogenic variants is associated with tumor stage and differentiation of human hepatocellular carcinoma.
    Chesnokov MS; Khesina PA; Shavochkina DA; Kustova IF; Dyakov LM; Morozova OV; Mugue NS; Kudashkin NE; Moroz EA; Patyutko YI; Lazarevich NL
    PeerJ; 2018; 6():e4915. PubMed ID: 29888133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases.
    Poltorak Z; Cohen T; Neufeld G
    Herz; 2000 Mar; 25(2):126-9. PubMed ID: 10829252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.